Clinical Trials
9 trialsNCT03382574 2022-06-14
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Terminated
NCT04476251 2021-12-15
E7 TCR T Cell Induction Immunotherapy for Stage IIB-IVA Cervical Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT01479348 2020-06-02
Imaging Study for FdCyd and THU Cancer Treatment
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT01086696 2019-12-17
A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT01413451 2019-12-17
Amatuximab for High Mesothelin Cancers
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT02317341 2019-03-20
Effect of Ketamine on Fatigue Following Cancer Therapy
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT01445054 2019-03-11
111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT02069080 2018-07-12
Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT00835679 2014-05-23
Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Terminated